Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B virus (HBV) is a small, enveloped DNA virus that infects the liver and causes hepatitis B, a disease that can be either acute or chronic. HBV infection is a major global health concern, leading to significant morbidity and mortality due to its association with cirrhosis and hepatocellular carcinoma (liver cancer).
Inhibition of viral polymerase activity (Entecavir, Tenofovir), Immunomodulation (Interferon alpha)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B Virus (HBV).